制瘤素M通过激活Müller细胞减少视网膜病理性新生血管形成
该研究在体外检测制瘤素M(OSM)对内皮细胞的促血管生成作用,并在氧诱导视网膜病变(OIR)小鼠模型中评估玻璃体内注射OSM的体内效应。尽管OSM在体外诱导促血管生成反应,但在OIR模型中玻璃体内注射OSM使视网膜新生血管减少65.2%、血管闭塞减少45.5%,并激活包括Müller细胞在内的多种视网膜细胞STAT3信号通路。
要点
- 在OIR模型中,玻璃体内注射OSM使视网膜新生血管减少65.2%、血管闭塞减少45.5%。
- 玻璃体内注射OSM激活包括Müller细胞在内的多种视网膜细胞STAT3信号通路。
- 体外OSM处理增加Müller细胞CXCL10分泌,而体内OSM处理后分选血管内皮细胞中血管生成和丝分裂相关基因下调。
核心结论
- 在体内,OSM通过激活Müller细胞并改变其分泌组而表现出有益的血管调节作用。
- 数据强调细胞因子在体外和体内的效应存在矛盾,取决于介导效应的细胞类型。
研究设计与样本
- 体外采用球体出芽实验和RNA测序检测OSM对内皮细胞的作用。
- 体内采用氧诱导视网膜病变(OIR)小鼠模型评估OSM的影响。
- 通过蛋白质印迹和视网膜冰冻切片检测信号模式;使用原代Müller细胞培养评估OSM对Müller细胞分泌组的影响。
- 使用荧光激活细胞分选(FACS)从OIR视网膜分离小鼠视网膜血管内皮细胞并进行RNA测序。
主要发现
- 尽管OSM在体外诱导促血管生成反应,但在OIR模型中玻璃体内注射OSM使视网膜新生血管减少65.2%、血管闭塞减少45.5%。
- 玻璃体内注射OSM激活包括Müller细胞在内的多种视网膜细胞STAT3信号通路。
- 体外OSM处理增加CXCL10分泌。
- OIR P17时OSM处理后分选血管内皮细胞的RNA测序显示血管生成和丝分裂相关基因下调。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Continuous vision loss due to vasoproliferative eye disease still represents an unsolved issue despite anti-vascular endothelial growth factor (VEGF) therapy. The impact of signal transducer and activator of transcription 3 (STAT3) signaling on retinal angiogenesis and its potential use as a therapeutic target remain controversial. In vitro, oncostatin M (OSM), as a strong STAT3 activator, possesses robust proangiogenic activity. This study investigated to what extent the proangiogenic effects of OSM translate to the in vivo setting of vasoproliferative eye disease. METHODS: The in vitro effect of OSM on endothelial cells was investigated in the spheroid sprouting assay and through RNA sequencing. The mouse model for oxygen-induced retinopathy (OIR) was used to evaluate the impact of OSM in vivo. Signaling patterns were measured by western blot and retinal cryosections. Primary Müller cell cultures were used to evaluate the effect of OSM on the Müller cell secretome. Murine retinal vascular endothelial cells were isolated from OIR retinas using fluorescence-activated cell sorting (FACS) and were used for RNA sequencing. RESULTS: Although OSM induced pro-angiogenic responses in vitro, in the OIR model intravitreal injection of OSM reduced retinal neovascularization by 65.2% and vaso-obliteration by 45.5% in Müller cells. Injecting OSM into the vitreous activated the STAT3 signaling pathway in multiple retinal cell types, including Müller cells. In vitro, OSM treatment increased CXCL10 secretion. RNA sequencing of sorted vascular endothelial cells at OIR P17 following OSM treatment indicated downregulation of angiogenesis- and mitosis-associated genes. CONCLUSIONS: In vivo, OSM reveals a beneficial angiomodulatory effect by activating Müller cells and changing their secretome. The data highlight contradictions between cytokine-induced effects in vitro and in vivo depending on the cell types mediating the effect.
引用
- Rapp J, Hospach A, Liang P, et al. Oncostatin M Reduces Pathological Neovascularization in the Retina Through Müller Cell Activation. Invest Ophthalmol Vis Sci. 2024. PMID: 38190125. doi:10.1167/iovs.65.1.22
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。